METAMeta Platforms
Our mission is to build the future of human connection and the technology that makes it possible. 10-K, Item 1
- Employees
- 78,865
- Headquarters
- Menlo Park, CA
- CEO
- Mark Zuckerberg
- Next results
- around Jan 27, 2027
What the debt is made of, and when it is due
balance sheet of Sep 30, 2026The debt note's own lines, 2025-12-31
| Line, as the company names it | Kind | Rate | Fixed or floating | Amount |
|---|---|---|---|---|
| November 2025 Notes | Notes and bonds | 4.20–5.77% | not stated | $30.0B |
| August 2024 Notes | Notes and bonds | 4.30–5.60% | not stated | $10.5B |
| August 2022 Notes | Notes and bonds | 3.50–4.71% | not stated | $10.0B |
| May 2023 Notes | Notes and bonds | 4.60–5.79% | not stated | $8.5B |
From the debt note in the 10-K's XBRL (0001628280-26-003942), as the company tags it: by issue, by year, by currency or by kind. Lines from two ways of cutting the same debt can overlap, so they are not added up. Fixed or floating is read from the line's own name only; "not stated" when it says neither.
Left: the debt lines on the balance sheet (XBRL). Right: the principal due each year, from the debt note's maturity schedule; it can differ a little from the balance sheet, which shows the debt net of discounts and fees. Leases are not counted.
When META has to repay the principal of its long-term debt, from the debt note of the 10-Q filed Oct 22, 2026 (balance sheet of Sep 30, 2026). Fiscal years are counted from that date.
| When | Principal due | Share | |
|---|---|---|---|
| Next 12 months FY2027 | $2.8B | 27% | |
| Year 2 FY2028 | $1.5B | 15% | |
| Year 3 FY2029 | $1.0B | 10% | |
| Year 4 FY2030 | $5.0B | 49% |
Principal only: interest, leases and commercial paper are not in this schedule. Hover a row for its XBRL line. Open the filing ↗
Work on META in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/META/export.csv") into a cell.